Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Breast Biopsy Rates Following BC Screening

JAMA Intern Med; 2018 Apr; Buist, et al

Women with and without a personal history of breast cancer (PHBC) who undergo screening magnetic resonance imaging (MRI) experience higher biopsy rates coupled with significantly lower cancer yield compared with screening mammography alone, a recent study found. The population-based cohort included 812,164 women undergoing screening (mammography vs MRI with or without mammography) from 2003 through 2013. A total of 2,048,994 digital mammography and/or breast MRI screening episodes were observed. Researchers found:

  • Age-adjusted core and surgical biopsy rates per 1,000 episodes doubled following MRI compared with mammography in women with PHBC.
  • Differences were even larger in women without PHBC: 84.7 following MRI and 14.9 following mammography episodes.
  • Lower invasive cancer and ductal carcinoma in situ yield for both groups was observed.
  • Higher biopsy rates and lower cancer yield following MRI was not explained by increasing age or higher 5-year breast cancer risk.

Citation:

Buist DSM, Abraham L, Lee CI, et al. Breast biopsy intensity and findings following breast cancer screening in women with and without a personal history of breast cancer. JAMA Intern Med. 2018;178(4):458–468. doi:10.1001/jamainternmed.2017.8549.

This Week's Must Reads

Do PCPs Recommend Medical Marijuana to Patients?, J Am Board Fam Med; 2018 Sep-Oct; Kondrad, et al

Intake of Sugars and Saturated Fats in US Children, Am J Clin Nutrit; ePub 2018 Sep 20; Wang, et al

Impact of Opioid Controlled Substance Agreements, Mayo Clin Proc; ePub 2018 Sep 20; Philpot, et al

MDD Screening Remains Low in Adolescents , J Pediatr; ePub 2018 Sep 21; Sekhar, et al

Subjective Wellbeing and Cardiometabolic Health, BMJ; ePub 2018 Sep 25; Wootton, et al

Must Reads in Oncology

FIT Performance & Optimal Positivity Thresholds, Ann Intern Med; ePub 2018 Sep 18; Selby, et al

Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0

Trends in HPV-Associated Cancers in the US, MMWR; 2018 Aug 24; Van Dyne, Henley, et al

Screening for Cervical Cancer in Primary Care, JAMA; 2018 Aug 21; Kim, Burger, et al

Endometrial Ca Risk with Postmenopausal Bleeding, JAMA Intern Med; ePub 2018 Aug 6; Clarke, et al